Trials / Completed
CompletedNCT01366248
Integrative Oncology Outcomes Study in Breast Cancer
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (actual)
- Sponsor
- Bastyr University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings. Hypothesis: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment on their own.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2011-06-06
- Last updated
- 2018-03-22
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01366248. Inclusion in this directory is not an endorsement.